Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5821109 | 0.88 | CETP (0.40) | CETPTACR1 | |
| SCHEMBL5140629 | 0.83 | TACR1 (0.41) | CETPTACR1 | |
| SCHEMBL5140076 | 0.80 | CETP (0.39) | CETP | |
| SCHEMBL5822402 | 0.78 | CETP (0.40) | CETPTACR1 | |
| SCHEMBL1601013 | 0.78 | CETP (0.45) | CETPTACR1 | |
| SCHEMBL1600532 | 0.78 | CETP (0.43) | CETPTACR1 | |
| SCHEMBL4173923 | 0.77 | TACR1 (0.42) | CETPTACR1 | |
| SCHEMBL6093458 | 0.77 | CETP (0.37) | CETP | |
| SCHEMBL13697600 | 0.76 | CETP (0.43) | CETPTACR1 | |
| SCHEMBL14416107 | 0.74 | CETP (0.43) | CETPTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1848430-A2 | NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS | Reddy US Therapeutics, Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2006073973-A2 | NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS | REDDY US THERAPEUTICS, INC. (US) | 2006-07-13 | — | — | WO | claimed |
| EP-1848430-A2 | NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS | Reddy US Therapeutics, Inc. (US) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006073973-A2 | NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS | REDDY US THERAPEUTICS, INC. (US) | 2006-07-13 | — | — | WO | disclosed |